Table 3. Results of the correlation analysis.
Group | VORT vs. |dCOP/dt| | nME vs. |dCOP/dt| | VUCM vs. COP(t) | ME vs. COP(t) | ||||
---|---|---|---|---|---|---|---|---|
Median | Q1, Q3 | Median | Q1, Q3 | Median | Q1, Q3 | Median | Q1, Q3 | |
PD patients | 0.11 | 0.04; 0.26 | 0.07 | 0.03; 0.20 | 0.17 | 0.13; 0.21 | 0.11 | 0.05; 0.19 |
Controls | 0.37 | 0.24; 0.42 | 0.31 | 0.24; 0.47 | 0.26 | 0.05; 0.39 | 0.10 | 0.08; 0.18 |
PD off-drug | 0.08 | 0.02; 0.16 | 0.07 | 0.04; 0.29 | 0.27 | 0.10; 0.38 | 0.09 | 0.02; 0.36 |
PD on-drug | 0.06 | 0.02; 0.09 | 0.07 | 0.05; 0.11 | 0.18 | 0.04; 0.26 | 0.14 | 0.07; 0.24 |
The median and inter-quartile values of the correlation coefficients between the VORT (nME) indices and the derivative of the COPAP (t), and between the VUCM (ME) indices and COPAP(t). Q1: the first quartile, Q3: the third quartile